Association of Healthy Lifestyle Behaviours With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study
- PMID: 39957597
- DOI: 10.1111/apt.70031
Association of Healthy Lifestyle Behaviours With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study
Abstract
Background: The combined effects of some modifiable lifestyle factors on incident inflammatory bowel disease (IBD) are uncertain.
Aims: To evaluate the combined association between healthy lifestyle behaviours and IBD incidence.
Methods: This population-based prospective cohort study used data from the UK Biobank. We included 105,715 participants aged 40-70 who had no IBD diagnosis at baseline in the analyses. The five healthy lifestyle behaviours that we studied were never smoking, optimal sleep, high level of vigorous physical activity, high dietary quality, and moderate alcohol intake. The outcome was the overall incidence of IBD and individual incidences of Crohn's disease (CD) and ulcerative colitis (UC). We derived hazard ratios (HR) and 95% confidence intervals (CI) for associations.
Results: The multivariable adjusted HRs (95% CI) associated with having 1, 2 and 3-5 healthy lifestyle behaviours for IBD incidence compared with those with none of these behaviours were 0.75 (0.59-0.97), 0.72 (0.56-0.92), and 0.50 (0.37-0.68), respectively (p for trend < 0.001). We observed similar findings for CD and UC. Only never smoking exhibited significant independent inverse associations with the overall incidence of IBD (HR 0.70, 95% CI 0.58-0.83, p < 0.001) and the incidence of UC (HR 0.58, 95% CI 0.48-0.72, p < 0.001).
Conclusions: Healthy lifestyle behaviours are significantly associated with lower IBD incidence in middle-aged and elderly individuals, suggesting the potential of lifestyle modifications as a primary prevention strategy for IBD.
Keywords: healthy lifestyle behaviours; inflammatory bowel disease; prospective cohort study.
© 2025 John Wiley & Sons Ltd.
References
-
- T. Sairenji, K. L. Collins, and D. V. Evans, “An Update on Inflammatory Bowel Disease,” Primary Care; Clinics in Office Practice 44 (2017): 673–692.
-
- D. C. Baumgart and S. R. Carding, “Inflammatory Bowel Disease: Cause and Immunobiology,” Lancet 369 (2007): 1627–1640.
-
- Y. Shao, Y. Zhao, H. Lv, et al., “Clinical Features of Inflammatory Bowel Disease Unclassified: A Case‐Control Study,” BMC Gastroenterology 24 (2024): 105.
-
- S. Alatab, S. G. Sepanlou, K. Ikuta, et al., “The Global, Regional, and National Burden of Inflammatory Bowel Disease in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017,” Lancet Gastroenterology & Hepatology 5 (2020): 17–30.
-
- S. C. Ng, H. Y. Shi, N. Hamidi, et al., “Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population‐Based Studies,” Lancet 390 (2017): 2769–2778.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical